tiprankstipranks
Trending News
More News >
Eagle Pharmaceuticals Inc (EGRX)
OTHER OTC:EGRX
US Market

Eagle Pharmaceuticals (EGRX) Balance Sheet

Compare
212 Followers

Eagle Pharmaceuticals Balance Sheet

Eagle Pharmaceuticals's total assets for Q2 2023 were $404.82M, a decrease of -2.26% from the previous quarter. EGRX total liabilities were $152.78M for the fiscal quarter, a -10.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 406.16M$ 253.73M$ 253.19M$ 254.55M$ 238.60M
Total Liabilities
$ 172.60M$ 77.28M$ 67.18M$ 75.38M$ 77.84M
Total Equity Gross Minority
$ 233.56M$ 176.45M$ 186.01M$ 179.17M$ 160.76M
Other Metrics
Currency in USD

Eagle Pharmaceuticals Debt to Assets